Solifenacin Reduces Overactive Bladder Symptoms and Improves Health-related Quality of Life in Patients Previously Treated with Tolterodine
Karram M1, Chancellor M2, Andoh M3 1. Tri-State Urogyenecology, Cincinnati, OH, 2. University of Pittsburgh, Pittsburgh, PA, 3. Astellas Pharma, Inc., Deerfield, IL
|
|
Abstract 332
|
|
|
Read By Title
Scientific Non Discussion Abstract Session 19
|
|
|